Published in Ann Rheum Dis on April 01, 2002
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther (2005) 1.58
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. Arthritis Res Ther (2004) 1.38
Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Ann Rheum Dis (2004) 1.38
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study. Arthritis Res Ther (2004) 1.17
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study. Arthritis Res Ther (2006) 1.17
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int (2004) 0.93
Etanercept and venous thromboembolism: a case series. J Med Case Rep (2010) 0.89
Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model. Arthritis Rheumatol (2015) 0.84
Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report. Med Sci Monit (2014) 0.78
Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers. Ann Rheum Dis (2004) 0.75
TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD. Curr Health Sci J (2014) 0.75
Response to the comment by Park et al. entitled "is there is a link between Escherichia coli septicaemia and the onset of systemic lupus erythematosus?". Rheumatol Int (2013) 0.75
Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha. J Thromb Thrombolysis (2017) 0.75
Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med (1996) 3.27
Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A (1994) 1.97
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) (2006) 1.74
Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Lancet (2000) 1.39
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther (2009) 1.08
Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med (1997) 1.06
Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J Virol (2001) 1.02
Twist is substrate for caspase cleavage and proteasome-mediated degradation. Cell Death Differ (2006) 0.99
Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J Infect Dis (1995) 0.95
Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res (1983) 0.95
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia (2006) 0.92
A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story... J Neuroendocrinol (2008) 0.92
Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int J Cancer (1998) 0.91
Cutting-edge issues in celiac disease and in gluten intolerance. Clin Rev Allergy Immunol (2012) 0.90
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) (2006) 0.88
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years. Rheumatology (Oxford) (2002) 0.87
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure. Eur J Med Res (2009) 0.86
Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives. Clin Exp Rheumatol (2000) 0.85
Transcriptional behavior of DMD gene duplications in DMD/BMD males. Hum Mutat (2009) 0.85
ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes (1988) 0.83
Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells Mol Dis (2002) 0.82
Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Rheumatology (Oxford) (2002) 0.82
Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes (1989) 0.81
[TNF- alpha gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-alpha agents: preliminary results]. Reumatismo (2002) 0.78
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. Ann Rheum Dis (2008) 0.78
Heterogeneity of rat neurofilament polypeptides revealed by a monoclonal antibody. J Neurochem (1986) 0.78
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. Eur J Cancer (1997) 0.77
Microthrix parvicella foaming at the Fusina WWTP. Water Sci Technol (2002) 0.77
Rat NGF receptor is recognized by the tumor-associated antigen monoclonal antibody 217c. Exp Neurol (1991) 0.77
Gangliosides prevent the inhibition by K-252a of NGF responses in PC12 cells. Brain Res Dev Brain Res (1992) 0.77
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis. Rheumatology (Oxford) (2007) 0.76
High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience. Clin Exp Rheumatol (1996) 0.76
Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses? Ann Rheum Dis (1997) 0.75
Etanercept in rheumatoid arthritis. N Engl J Med (1999) 0.75
Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy. J Rheumatol (1998) 0.75
Schwann cells transplanted in the lateral ventricles prevent the functional and anatomical effects of monocular deprivation in the rat. Proc Natl Acad Sci U S A (1994) 0.75
Response of mononuclear cells to lipopolysaccharide and CpG oligonucleotide stimulation: possible additive effect in rheumatoid inflammation. Ann Rheum Dis (2003) 0.75
Production and characterization of monoclonal antibodies to human ciliary neurotrophic factor with defined epitope recognition. Hybridoma (1993) 0.75
Processes of peripheral nerve and neuromuscular repair. Ann Ist Super Sanita (1988) 0.75
IL-6 and some natural inhibitors of chronic human inflammation in RA and SLE. Clin Exp Rheumatol (1999) 0.75
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? Br J Dermatol (2012) 0.75
Antiproliferative activity of unfractioned heparin on a human smooth muscle cell line. Pharmacol Res (1990) 0.75
[Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis]. Reumatismo (2009) 0.75
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association. Ann Rheum Dis (2003) 0.75
Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study. Diabetologia (1990) 0.75
A developmentally regulated isoform of 150,000 molecular weight neurofilament protein specifically expressed in autonomic and small sensory neurons. Neuroscience (1987) 0.75
[B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis]. Reumatismo (2004) 0.75
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. Rheumatology (Oxford) (2006) 0.75
[Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE]. Reumatismo (2003) 0.75
Abnormalities of autonomic nervous system in hyperadrenergic orthostatic hypotension: description of a case. Int J Cardiol (1995) 0.75